NCT03435471 Outcomes of Prophylactic Swallowing Therapy in Patients Undergoing Definitive Chemoradiation for Head and Neck Cancer Status COMPLETED Phase NA
NCT03431363 Medical Cannabis During Chemoradiation for Head and Neck Cancer Status COMPLETED Phase N/A
NCT03422536 Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma Status COMPLETED Phase PHASE2
NCT03418792 Functional Sparing of Salivary Glands Using MRI Sialography for Patients Undergoing Definitive Radiation Therapy for Head and Neck Cancers of the Oropharynx Status COMPLETED Phase NA
NCT03416582 Feasibility Study of a Nurse Intervention to Impact Mucositis Severity and Prevent Dehydration Status COMPLETED Phase NA
NCT03405142 Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head&Neck Cancer Status COMPLETED Phase PHASE2
NCT03403361 Dual-Energy CT on Plan Quality, Dose-delivery Accuracy, and Simulated Outcomes of Patients Treated With Proton or Photon Therapy Status TERMINATED Phase NA
NCT03386838 An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck Status WITHDRAWN Phase PHASE3
NCT03380208 Comparison of Endoscopic Visualization and CT Imaging of Head and Neck Cancers With Pathological Validation Study Status COMPLETED Phase N/A
NCT03377270 Clinical Impact of Respiratory-Swallow Training on Refractory Dysphagia in Oropharyngeal Head and Neck Cancer Status COMPLETED Phase NA
NCT03376386 Adaptive Dose-Escalated Multi-modality Image-guided RadiothErapy Status COMPLETED Phase NA
NCT03372148 Role of Pharyngeal High Resolution Manometry and Impedance in Swallow Function of Head and Neck Cancer Patients Status WITHDRAWN Phase NA
NCT03360695 Bridge: Proactive Psychiatry Consultation and Case Management for Patients With Cancer Status COMPLETED Phase NA
NCT03359187 Prevention of Mucositis in Patients With Head and Neck Cancer Treated With Radiotherapy Status COMPLETED Phase NA
NCT03358472 Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304) Status COMPLETED Phase PHASE3
NCT03356223 Evaluation of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Cancer After Failure of Platinum and Cetuximab or Anti-EGFR-based Therapy and Harboring an Homozygous Deletion of CDKN2A, and/or an Amplification of CCND1 and/or of CDK6 Status COMPLETED Phase PHASE2
NCT03355560 Adjuvant Nivolumab After Salvage Resection in Head and Neck Cancer Patients Previously Treated With Definitive Therapy Status COMPLETED Phase PHASE2
NCT03349034 Local Infusion of Ropivacaine for Post-Op Pain Control After Osseocutaneous Free Flaps Status COMPLETED Phase PHASE2